CXCL10 is thought to be a key chemoattractant in diabetes pathogenesis and has been found elevated at early stages of T1D in rodent and human studies [52,53,54], including in serum from individuals with newly diagnosed T1D [55,56]. This evidence concerns the gene CXCL10 and type 1 diabetes mellitus.